Aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor, in the involved epidermis of patients with vitiligo

British Journal of Dermatology

Volumn 146, Issue 1, 2002, Pages 80-87

  Van Den Wijngaard, R M J G J ^a   Asghar, S S ^a   Pijnenborg, A C L M ^a   Tigges, A J ^a   Westerhof, W ^a,b   Das, P K ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Dutch Institute for Pigmentary Disorders (SNIP)   (Netherlands)

Author keywords

CD59; Complement; Decay accelerating factor; Melanocyte; Membrane cofactor protein; Vitiligo

Indexed keywords

AUTOANTIBODY; CD59 ANTIGEN; DECAY ACCELERATING FACTOR; MEMBRANE COFACTOR PROTEIN; REGULATOR PROTEIN;

ANTIBODY SPECIFICITY; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EPIDERMIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; KERATINOCYTE; MELANOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN DEFECT; VITILIGO;

ANTIGENS, CD; ANTIGENS, CD46; ANTIGENS, CD55; ANTIGENS, CD59; CASE-CONTROL STUDIES; CELLS, CULTURED; COCULTURE TECHNIQUES; EPIDERMIS; FLOW CYTOMETRY; HUMANS; KERATINOCYTES; MELANOCYTES; MEMBRANE GLYCOPROTEINS; VITILIGO;

EID: 0036181531     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.04604.x     Document Type: Article

References (22)

1. On the etiology of vitiligo and gray hair
2. Presence or absence of melanocytes in vitiligo lesions: An immunohistochemical investigation
3. An immunohistological study of cutaneous lymphocytes in vitiligo
4. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance
5. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo
6. Evidence for immunologic mechanisms in human vitiligo: Patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity
7. Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo
8. In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo
9. Antibodies to normal human melanocytes in vitiligo
10. The significance of vitiligo antibodies
11. Coexistence and relationship of anti-keratinocyte and anti-melanocyte antibodies in patients with non-segmental-type vitiligo
12. Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay
13. A melanosomal membrane protein is a cell surface target for melanoma therapy
14. Implicating a role for immune recognition of self in tumor rejection: Passive immunization against the brown locus protein
15. Complement as a promiscuous signal transduction device
16. Intrinsic regulators of complement activation in vitiligo
17. Relative contributions of decay accelerating factor (DAF), membrane cofactor protein (MCP) and CD59 in the protection of melanocytes from homologous complement
18. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
19. Practical suggestions for successful immunoenzyme double-staining experiments
20. Phagocytosis by normal human melanocytes in vitro
21. Glycosylphosphatidylinositol (GPI)-anchored membrane proteins are constitutively down-regulated in psoriatic skin
22. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells